https://bioconbiologics.com

Biocon Biologics - Transforming Healthcare. Transforming Lives.Driven by our collective vision of transforming healthcare and transforming patients’ lives, Biocon Biologics is making healthcare affordable and importantly accessible to millions of patients and their families across the world.Biocon Biologics - Transforming Healthcare. Transforming Lives. Our World Brazil Egypt Europe Hong Kong Malaysia Mexico Morocco Philippines Saudi Arabia South Africa Taiwan Thailand Tunisia Turkey UAE USA Vietnam Global HQ Contact Us About Us Overview Our Business Board of Directors Leadership Team Scientific Publications Awards & Recognition Our Legacy Products Overview Product Locator Business Overview Global Biosimilars Portfolio Global Footprint Partners Emerging Markets Biocon Biologics U.S. Biocon Biologics EU Capabilities Research & Development Quality & Compliance Global Scale Manufacturing Malaysia Commitment Overview EHS Certifications Investors Overview Corporate Governance Board Committees Governance & Policies Corporate Structure Speak-up Hotline Financial Information Annual Reports Subsidiary Financials Investor Presentations Shareholder Services General Meeting News Overview Press Releases Company Statements Stories Media Stories Media Contacts Video Gallery Resource Center Careers Working With Us Now Hiring Stories Overview Brand Stories Patients’ Stories Employee Stories Transforming Healthcare. Transforming Lives. Biocon Biologics Continues to be Among Science Magazine's Top 10 Global Employers List Know More Ranked at No.9 & voted as ‘Innovative Leader in the Industry’ for over a decade. Biocon Biologics crosses billion-dollar milestone, with 58% rise in annual revenue Know More Biocon Biologics is transforming patient outcomes by making life-changing therapies more accessible to the world. Through affordable biosimilars, we are reducing the global healthcare burden, increasing treatment options and driving innovation in biologics, to advance health equity, globally. KNOW MORE Our Differentiators Integrated to Scale Transform patients’ lives by delivering affordable access to innovative and inclusive healthcare solutions. BIOCON LEGACY Biocon’s rich legacy of being at the cutting edge of science is enabling us to enable health equity worldwide. EXPANSIVE PORTFOLIO An expansive portfolio of biosimilars spanning insulins, monoclonal antibodies and conjugated recombinant proteins. GLOBAL PRESENCE A commercial footprint stretching to over 100 countries, which includes both advanced and emerging markets. Our Impact ~5.5 Million Patients benefit from our biosimilars, annually ~7.3 Billion Doses of insulins supplied to patients globally since 2004 20 Biosimilars In the portfolio 8 Biosimilars Commercialized in global markets Our Firsts 2004 World’s 1st Pichia pastoris technology based rh-Insulin developed and commercialized in India 2017 1st company globally to get U.S. FDA approval for bTrastuzumab 2018 1st company globally to get U.S. FDA approval for bPegfilgrastim 2021 1st company globally to commercialize interchangeable bGlargine in U.S. 2024 1st company to get U.S. FDA approval for interchangeable bAflibercept Our Commitment At Biocon Biologics, we are driven by a humanitarian purpose to make healthcare affordable and accessible to even the poorest of patients. This philosophy resonates with our Environmental, Social and Governance (ESG) practices, which stand on the five pillars of Patient Equity, People Equity, Environment Equity, Stakeholder Equity, Social Equity. Know More News U.S. FDA Classifies Biocon Biologics Site in Johor Bahru, Malaysia as Voluntary Action Indicated (VAI) Jan 12, 2024 Biocon Biologics to Present at the 43rd Annual J.P. Morgan Healthcare Conference Jan 09, 2025 Biocon Biologics Completes One Year as an Integrated Global Biosimilars Enterprise Jan 07, 2025 Japan Health Authority (PMDA) Approves Biocon Biologics’ Ustekinumab BS, Biosimilar to J&J’s Stelara® Jan 07, 2025 Know More Leveraging THE POWER OF ONE Biocon Biologics has acquired the global biosimilars business of Viatris to become a Unique, World-Class, Fully Integrated Biosimilars Leader We are enabling affordable access to lifesaving biosimilars worldwide. Know More Video >> Quick LinksAbout Us News Our Stories Investors Biocon Limited Syngene Biocon Foundation Biocon Academy BusinessU.S. Europe RECOMMENDED SITESScience Gallery ABLE Immuneel Therapeutics Bicara Therapeutics Equillium Biocon Blog Get in TouchContact Us Sitemap Report adverse events/side effects/product complaints and/or to submit medical inquiries for Biocon Biologics Limited & BBL Affiliate products. * Cookie Policy | Privacy Policy | Terms of Use © 2025, Biocon Biologics Limited (a Subsidiary of Biocon Limited). All Rights Reserved Leaving the Biocon Biologics Corporate Website You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics U.S. Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country. Agree >> CLOSE Leaving the Biocon Biologics Corporate Website You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics EU Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country. Agree >> CLOSE Leaving the Biocon Biologics site You are now leaving the Biocon Biologics page for a Biocon Biologics affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country. Agree >> CLOSE buy twitter followers - omegle - matadorbet güncel adres - onwinenusen-US1737884401https://bioconbiologics.com

Edit your site?

What are you doing?